To further characterize the leptin resistant phenotype observed in males at the endocrine level, we randomly selected eight males from TBT and control groups and analyzed a panel of seven metabolites related to metabolic diseases; we did not find significant changes in any of the metabolites analyzed (Supplementary Table 4). The gene discussed is LEP; the disease is metabolic disease.